dr. elise héon, a clinician-scientist in the field of ocular genetics with the hospital for sick children in toronto, which will be one of the sites for treatment in canada, says the approval of this drug is “ a significant step forward.”
advertisement
novartis pharmaceuticals canada inc. has not disclosed the cost of the drug yet, but in the u.s., where luxturna has been available since september 2017, a one-time treatment for both eyes costs usd $850,000. this could convert to more than $1.1 million in canada, which would make it one of the world’s most expensive drugs .
advertisement
dduong@postmedia.com
|
@dianaduo
don’t miss the latest on covid-19, reopening and life. subscribe to healthing’s daily newsletter covid life.